News Stories
The FDA Just Held Its First Hearing on Psychedelic Medicine
Four hours at the FDA made it official: approving a psychedelic is the easy part.…
Locked in Schedule 1. UK and the Psilocybin Question
A recent nationwide poll finds broad support for psilocybin-assisted therapy in the UK. But does…
Europe's Psychedelic Moment: ICPR Conference 2026
ICPR 2026, Europe's premier psychedelic research conference, ran June 4–6 in Haarlem with 100+ speakers…
"The Whole World in One Fractal" — A TRYP Expo Recap
TRYP Expo 2026 brought 80+ speakers and 150+ exhibitors to Berlin's Funkhaus for Europe's largest…
A Deeper Look at the U.S.’ Psychedelic Executive Order
Trump's April 2026 executive order gives psychedelics $50M in funding and faster FDA review —…
Global Psychedelic Week 2025: 7 Must-See Speakers, 5000 Participants, 100 Countries
States of Mind is participating in the Global Psychedelic Week conference as a supporting media…
The Fight for 7-OHM: Inside the Movement to Legitimize a Controversial New Plant Medicine
A new conversation (and controversy) is unfolding around 7-OHM in the world of plant medicine.
